O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

We evaluated the pharmacodynamic effects of the O(6)-methylguanine-DNA methyltransferase (MGMT) inactivator lomeguatrib (LM) on patients with melanoma in two clinical trials. Patients received temozolomide (TMZ) for 5 days either alone or with LM for 5, 10 or 14 days. Peripheral blood mononuclear ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, A J, Middleton, M R, McGown, G, Thorncroft, M, Ranson, M, Hersey, P, McArthur, G, Davis, I D, Thomson, D, Beith, J, Haydon, A, Kefford, R, Lorigan, P, Mortimer, P, Sabharwal, A, Hayward, O, Margison, G P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676560/
https://www.ncbi.nlm.nih.gov/pubmed/19367283
http://dx.doi.org/10.1038/sj.bjc.6605015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676560/
https://www.ncbi.nlm.nih.gov/pubmed/19367283
http://dx.doi.org/10.1038/sj.bjc.6605015

Ejemplares similares